Cargando…
P45 Antimicrobial activity of ruthenium-based metallo-therapeutics against Pseudomonas aeruginosa
BACKGROUND: Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that is highly resistant to antibiotics and biocidal products used in both medical and industrial environments respectively. Metal-based compounds have been used as antimicrobial agents throughout history for a broad range...
Autores principales: | Britten, Nicole S., Butler, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849327/ http://dx.doi.org/10.1093/jacamr/dlac004.044 |
Ejemplares similares
-
1241. In Vivo Efficacy of Meropenem Against Metallo-ß-Lactamase (MBL)-Harboring Pseudomonas aeruginosa and Correlation to In Vitro Susceptibility Upon Addition of EDTA
por: Kois, Abigail K, et al.
Publicado: (2021) -
195. Antimicrobial Stewardship Incorporating New Antimicrobials for Use against Multi-Drug Resistant Pseudomonas aeruginosa in Cystic Fibrosis
por: Jo, Jinhee, et al.
Publicado: (2020) -
A novel ruthenium-silver based antimicrobial potentiates aminoglycoside activity against Pseudomonas aeruginosa
por: Donkor, Gracious Yoofi, et al.
Publicado: (2023) -
P24 Cefiderocol activity against a multidrug-resistant (MDR) strain of Pseudomonas aeruginosa: a case report
por: Lim,, Felicia H., et al.
Publicado: (2022) -
606. Identification and Characterization of HMB-2, a Novel Metallo-β-Lactamase in a Pseudomonas aeruginosa Isolate
por: Zhu, Wenming, et al.
Publicado: (2019)